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The purpose of this study was to test the hypothesis that 
orthostatic stress shortens the right ventricular effective 
refractory period by reflex activation of beta-adrenergic 
receptors. Twelve patients undergoing electrophysiologic 
testing for standard clinical indications were studied. After 
a full electrophysiologic study, patients underwent graded 
lower body negative pressure before and after administra-
tion of either propranolol (0.2 mg/kg intravenously) in 
Group I or atropine (0.035 mg/kg intravenously) in Group 
II. 
Before the addition of drugs, lower body negative 
pressure produced decreases in systolic blood pressure and 
significant increases in sinus rate. The effective refractory 
period shortened from 214 ± 8 (mean ± SEM) to 206 ± 7 
Autonomic influences play an important role in ventricular 
arrhythmogenesis, particularly after myocardial infarction. 
Parasympathetic influences are believed to protect against 
arrhythmias and beta-adrenergic influences are thought to be 
arrhythmogenic in experimental animals (1-3) and in humans 
(4--7). The electrophysiologic mechanisms for these effects 
are not known, but they may be direct, acting on the tissue 
responsible for tachycardia (2), or indirect (3) by reduction 
of heart rate. 
It is well known that beta-adrenergic influences shorten 
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ms at -40 cm H20 and to 197 ± 4 ms at -60 cm H20 lower 
body negative pressure. After propranolol, Group I pa-
tients had no change in right ventricular effective refractory 
period despite similar changes in sinus rate and systolic 
blood pressure. In Group II patients, atropine did not alter 
effective refractory period responses to lower body negative 
pressure. 
Thus, reflex adjustments to orthostatic stress result in 
shortening of right ventricular effective refractory period 
mediated by way of beta-adrenergic mechanisms. These 
findings constitute the first evidence that sympathetic influ-
ences mobilized by the body can directly modulate ventric-
ular electrophysiologic changes. 
(J Am Coil CardioI1988;I2:1488-93) 
the ventricular effective refractory period in animals (8,9) 
and humans (7). Human studies like the latter have involved 
infusions of arbitrary doses of isoproterenol, which might 
have questionable physiologic significance. Even though 
propranolol prolongs baseline ventricular effective refrac-
tory period in anesthetized animals (1,8,9), it does not 
substantially affect that in humans at rest (10), perhaps 
because there is only a small amount of background sympa-
thetic input to the ventricle in a patient undergoing clinical 
electrophysiologic testing of the ventricle. We reasoned that 
the beta-blocking effects of propranolol would be demonstra-
ble in patients if background sympathetic influences were 
augmented by an autonomic reflex. We therefore studied the 
effects of lower body negative pressure on the right ventric-
ular effective refractory period in patients because lower 
body negative pressure is an extremely well studied physio-
logic stimulus (II), that increases both circulating catechol-
amines (11,12) and sympathetic neural firing (13) in humans. 
We tested the hypotheses that lower body negative pressure 
would shorten right ventricular effective refractory period 
and that this shortening would be mainly due to sympathetic 
influences that could be blockeq b'y propranolol. 
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Table 1. Clinical Features of 12 Patients 
Patient Age (yr) 
No. & Gender Cardiac Disease 
Group I 
I 71F None 
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Indication For EPS Results of EPS 
Syncope (VT-NS) Negative 
1489 
2 36M Myocardial infarction Palpitation (VT-NS) Negative 
3 33F Mitral prolapse Syncope (VT-NS) Negative 
4 24F None (VT-Sus) VT Sus 
5 69M None Syncope (SVT) SVT (AVNR) 
6 67M None Presyncope (VT-NS) VT-NS 
Group II 
7 23M None Syncope (unknown) SVT (AVNR) 
8 37M Aortic regurgitation Syncope (VT-NS) VT-NS 
9 49F None Cardiac arrest (VT-NS) VT-NS 
10 39M None Syncope (seizure) Negative 
II 50M Cardiomyopathy Syncope (VT-NS) Negative 
12 33F None Syncope (unknown) Negative 
AVNR = atrioventricular node reentry; EPS = electrophysiologic study; F = female; M = male; NS = 
nonsustained; Sus = sustained; SVT = supraventricular tachycardia; VT = ventricular tachycardia. 
Methods 
Study patients (Table 1). Twelve patients presenting with 
symptoms of syncope or palpitation or known arrhythmias 
were studied. The patients were invited to participate in the 
study after its goals were explained, and each gave written 
informed consent for the research protocol approved by the 
Human Use Committee of the University of Iowa. 
Electrophysiologic testing. All patients underwent elec-
trophysiologic testing in the postabsorptive and non sedated 
state and were not receiving cardioactive medications. Two 
quadripolar catheters were placed in the femoral veins by the 
Seldinger technique under local lidocaine anesthesia (l to 2 
ml of 1% solution). The extrastimulus protocol for the 
clinical electrophysiologic study was performed as previ-
ously reported from this laboratory (7,14). 
The study protocol followed completion of the clinical 
study. A quadripolar catheter was placed in the right ven-
tricular apex and thresholds were recorded to the nearest 0.1 
rnA. Pacing was performed at four times threshold to de-
crease the variability of refractory period measurements 
occurring at two times threshold, owing to the varying shape 
of the strength-interval relation in normal and abnormal 
ventricular myocardium (15). The current for pacing set at 
the beginning of the study was maintained throughout all 
subsequent testing including threshold determinations. Pre-
liminary extrastimulus testing was performed to assure sta-
ble pacing without artificial repetitive responses. The cath-
eter was then fixed to the skin and sterile drape with a plastic 
adhesive sheet that prevented catheter movement. The 
sterile drape was folded so that it lay immediately above the 
patient, exposing the lateral aspects of the patient's legs and 
hips. The patient was placed in a lower body negative 
pressure chamber, which was advanced to the level just 
below the iliac crest. A seal was formed by applying adhe-
sive tape circumferentially around the patient's abdomen. 
The folded sterile sheet containing the catheters exiting from 
the pressure chamber was placed under the seal. 
Lower body negative pressure. After satisfactory seal 
resulting in a range of lower body negative pressure from 
-20 to -60 cm H20, repeat threshold testing was performed 
at the right ventricular apex at a basic cycle length of 450 ms 
(lasting approximately 20 to 30 s). Then a premature stimulus 
(followed by a train delay) was administered to the same 
electrodes at a coupling interval approximately 30 to 50 ms 
longer than the estimated effective refractory period. After 
capture occurred, the premature stimulus interval was short-
ened in decrements of 5 ms after each eight basic stimuli 
until failure to capture occurred. After this sequence, the 
premature interval was prolonged by 10 ms and the proce-
dure of decrementing the premature interval was repeated. 
The effective refractory period was defined as the longest 
premature interval for which the premature stimulus did not 
evoke a response. The data reported herein are those that 
were reproducible, defined as obtaining the same value of 
refractoriness on two separate trials. In addition, threshold 
measurements were unchanged, defined as varying :sO. 1 rnA 
throughout the course of testing with lower body negative 
pressure; threshold is not altered by sympathetic influences 
(8). 
Protocols. The sequence of study was as follows: control 
period; lower body negative pressure at three levels, -20, 
-40 and -60 cm H20; and recovery 5 min after cessation of 
lower body negative pressure. During each period, the 
spontaneous heart rate was measured for 60 s while blood 
pressure was measured by the inflatable cuff technique. 
Then ventricular pacing was begun to measure the effective 
refractory period. These measurements were performed 
after 1 min at each level of lower body negative pressure. 
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Table 2. Systolic Arterial Pressure Responses (mm Hg) 
LBNPO LBNP -20 LBNP -40 LBNP -60 Recovery 
Group I (n = 6) 
Baseline 119 ± 7 122 ± 4 119 ± 5 110 ± 3* 119 ± 9 
Propranolol 114 ± 5 116 ± 8 106 ± 6 108 ± 7 113 ± 4 
Group II (n = 6) 
Baseline 118 ± 7 119 ± 7 110 ± 4 110 ± 7 124 ± 14 
Atropine 127 ± 5 116 ± 7* 106 ± 3* Not done 128 ± 5 
*p < 0.05 vs. LBNP 0 for baseline or drug. LBNP = lower body negative pressure (cm H2O). 
After completion of measurements at each level, the next 
level of lower body negative pressure was applied without 
interruption. The time at each level of lower body negative 
pressure averaged 5 min. 
The patients were classified into two groups. The first 
group of six patients received propranolol at a dose of 0.2 
mg/kg. Repeat testing with lower body negative pressure 
was performed 20 min after administration of propranolol. In 
Group II, atropine (0.035 mg/kg intravenously) was admin-
istered by bolus injection and lower body negative pressure 
was repeated at levels of -20 and -40 cm H20. At lower 
body negative pressure of -60 cm H20, control of heart rate 
during ventricular pacing was inadequate. 
Data analysis. Data are expressed as mean ± SEM and 
were analyzed with an analysis of variance employing Dun-
nett's test for mUltiple comparisons (16). Paired Student's t 
tests were employed to compare variables before and after 
drug administration. Unpaired t tests were used to compare 
the two groups. A p value <0.05 was considered significant. 
Results 
Clinical features (Table 1). Our patients' ages ranged 
from 23 to 71 years; patients in Group I tended to be older, 
but this difference was not significant (p > 0.25). Moreover, 
the magnitude of baseline reflex responses (Tables 2 to 4) did 
not differ between the groups. Four patients had heart 
disease and all had clinical indications for electrophysiologic 
study. Six patients had no abnormalities at the electrophys-
iologic study, whereas three had nonsustained ventricular 
tachycardia, two had atrioventricular (A V) node reentrant 
Table 3. Heart Rate Responses (beats/min) 
LBNPO LBNP -20 
Group I (n = 6) 
Baseline 90 ± 6 86 ± 6 
Propranolol 70 ± 3t 66 ± 4 
Group II (n = 6) 
Baseline 76 ± 4 87 ± 3* 
Atropine 117 ± 5t 121 ± 6 
tachycardia and one had sustained ventricular tachycardia 
induced. 
Arterial pressure responses (Table 2). In Group I, systolic 
arterial pressure decreased reversibly at a lower body neg-
ative pressure of -60 cm H20, whereas in Group II, a 
similar magnitude of change did not result in a significant 
decrease. After propranolol administration in Group I, sys-
tolic blood pressure did not decrease significantly during 
lower body negative pressure. In Group II, systolic blood 
pressure decreased at lower body negative pressures of - 20 
and -40 cm H20 after atropine. 
Heart rate responses (Table 3). In Group I, sinus node 
rate increased at a lower body negative pressure of -60 cm 
H20. After propranolol administration, spontaneous heart 
rate slowed significantly compared with that before the drug 
was given. The sinus rate was not significantly altered by 
lower body negative pressure after propranolol. In Group II, 
sinus rate increased at all levels of lower body negative 
pressure. After atropine, baseline heart rate increased, but it 
did not increase further with lower body negative pressure. 
At a lower body negative pressure of -60 cm H20, sponta-
neous heart rate exceeded that during ventricular pacing; 
therefore data after atropine were not recorded. 
Effective refractory period responses (Fig. 1, Table 4). 
Before propranolol or atropine, the effective refractory 
period shortened in both groups during lower body negative 
pressures of -40 and -60 cm H20. Twenty minutes after 
intravenous administration of propranolol, the effective re-
fractory period was not significantly altered. Lower body 
negative pressure produced no change in effective refractory 
period at any negative pressure level after propranolol 
LBNP -40 LBNP -60 Recovery 
96 ± 5 109 ± 7* 89 ± 9 
74 ± 3 77 ± 3 69 ± 5 
87 ± 4* 104 ± 8* 77 ± 6 
126 ± 7 Not done 107 ± 5 
*p < 0.05 vs. LBNP 0; tp < 0.05 vs. recovery baseline. LBNP = lower body negative pressure Jcrri H20). 
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Table 4. Right Ventricular Effective Refractory Period Responses (ms) 
LBNP 0 LBNP -20 LBNP -40 LBNP -60 Recovery 
Group I (n = 6) 
Baseline 214 ± 8 213 ± 7 206 ± 7* 197 ± 4* 215 ± 6 
Propranolol 218 ± 3 220 ± 7 218 ± 5 223 ± 6 226 ± 6 
Group II (n = 6) 
Baseline 209 ± 5 202 ± 5 200 ± 4* 196 ± 3* 210 ± 8 
Atropine 199 ± 2 193 ± 2 192 ± 2* Not done 201 ± 2 
*p < 0.05 vs. LBNP. LBNP = lower body negative pressure (cm H2O). 
administration. At no time did the configuration of the 
surface electrocardiogram (ECG) or intracardiac electro-
gram change during pacing and at no time did the late 
diastolic threshold vary by >0.1 rnA. 
In Group II after atropine administration, the effective 
refractory period did not shorten significantly (p = 0.0. 
Lower body negative pressure still shortened the effective 
refractory period at -40 cm H20 after administration of 
atropine; this shortening expressed as percent of lower body 
negative pressure 0 (3.5 ± 1.1%) was not different from that 
occurring before atropine was given (4.5 ± 0.8%, p > 0.2). 
Discussion 
This study demonstrates two new observations. First, 
orthostatic stress (lower body negative pressure) shortens 
right ventricular effective refractory period through activa-
tion of beta-adrenergic receptors. Second, parasympathetic 
influences are not involved in controlling effective refractory 
Figure 1. Right ventricular effective refractory period (ERP) re-
sponses (in ms) at various levels of lower body negative pressure 
(LBNP) before and after propranolol administered intravenously. 
Before propranolol, there were graded decreases in effective refrac-
tory period. After propranolol, effective refractory period did not 
change. 
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period responses to orthostatic stress. These studies clearly 
demonstrate a physiologic role for the sympathetic nervous 
system in direct modulation of the duration of the ventricular 
refractory period. 
Comparison with previous studies. Lower body negative 
pressure in the present study was solely performed during 
electrophysiologic testing with the use of single extrastimuli 
to measure the ventricular effective refractory period. Be-
cause all measurements and extrastimulus testing were per-
formed in 4 to 5 min at each level of lower body negative 
pressure, near syncope did not occur, although others (17) 
observed it commonly when lower body negative pressure at 
levels of -40 and -60 mm Hg continued for >5 min. This 
lack of presyncope during lower body negative pressure in 
our study may have been due to our use of pacing at a cycle 
length of 450 ms, which reversed the bradycardia and 
hypotension occurring in the prior study (17). 
In our study, lower body negative pressure produced 
reversible shortening of the right ventricular effective refrac-
tory period measured at a constant pacing rate. Others (18) 
have measured the right ventricular effective refractory 
period during tilt and found that it also shortened to a similar 
degree. Although there are differences between these two 
interventions in that tilt stimulates the vestibular system and 
produces differential stimulation of carotid and aortic baro-
receptors (11,19), these apparently do not influence the 
ventricular effective refractory period responses. In addi-
tion, our study demonstrated that shortening of the effective 
refractory period was blocked entirely by intravenous pro-
pranolol in a dose that slowed baseline sinus rate. 
We did not demonstrate the significant alteration in 
ventricular effective refractory period with intravenous at-
ropine as previously reported by others (10). This lack of 
effect might have been due to the small number of patients in 
Group II, but a similar number of patients (five) was studied 
previously (10). More likely, because our patients underwent 
lower body negative pressure before the administration of 
atropine, this procedure may have conditioned them to have 
less parasympathetic influence at rest to the ventricle. We 
also did not observe atropine to potentiate the response to 
lower body negative pressure (greater shortening of effective 
refractory period); we did not see a blockade of the restrain-
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ing influence of the parasympathetic nerves on sympathetic 
function with atropine. This result may be due to the 
ventricular effects of parasympathetic influences produced 
by baroreflexes, which are small as compared with sympa-
thetic influences as manifested by previous animal experi-
ments (9). This disparity in magnitude of parasympathetic 
and sympathetic effects is especially prominent when there 
is coincident parasympathetic withdrawal and sympathetic 
activation during lower body negative pressure. 
Possible limitations of this study. We considered other 
possibilities to explain our results with propranolol in Group 
I. It could be argued that propranolol prevented lower body 
negative pressure from being an effective stress because of 
the blunted (nonsignificant) responses of the systolic blood 
pressure to lower body negative pressure. However, at a 
lower body negative pressure of -60 cm H20, a similar level 
of systolic arterial pressure was produced before and after 
propranolol, indicating that the stimulus of the lower body 
negative pressure was very similar before and after propran-
olol. A second possible concern was that the lack of effective 
refractory period response after propranolol reflected effects 
of the repeated application of lower body negative pressure 
and not drug effect (11). This possibility is unlikely because 
responses of the effective refractory period were preserved 
after atropine. The third possibility was that the stimulus of 
lower body negative pressure was altered because propran-
olol decreased left ventricular contractility and the sensitiv-
ity of cardiac afferents (20). However, effects on effective 
refractory period occurred at -40 and -60 cm H20 (corre-
sponding to -29 and -44 mm Hg) when the arterial and 
cardiac baroreflexes are activated by lower body negative 
pressure (20--22). Propranolol does not desensitize the arte-
rial baroreflex (20); thus, it is unlikely that the effects of 
propranolol on cardiac sensory receptors accounted for its 
effect on the ventricular effective refractory period. There-
fore, we conclude that propranolol prevented right ventric-
ular effective refractory period shortening during lower body 
negative pressure because of blockade of beta-receptors, 
which prevented expression of augmented sympathetic neu-
ral and humoral influence. 
With the use of catheter techniques, any change in the 
position of the heart, such as that which might occur with 
lower body negative pressure, may alter the recording and 
pacing sites. In this study, we carefully performed the 
following procedures to document that results of lower body 
negative pressure were accurately reflecting ventricular elec-
trophysiologic changes. First, threshold changes were mea-
sured with each intervention and found not to alter over the 
course of each study. Second, the effective refractory period 
returned to control level and lower body negative pressure. 
Third, the surface ECG and intracardiac electrograms did 
not change during ventricular pacing in any of the patients 
studied. Thus, the positional changes of the heart in the 
chest occurring with lower body negative pressure did not 
JACC Vol. 12, No.6 
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change the catheter position to another site which might 
have altered our data. 
Increases in sympathetic neural influence to the ventri-
cles may produce dispersion of ventricular refractoriness 
and may predispose to ventricular fibrillation (23). Changes 
in the right ventricular effective refractory period do not 
necessarily demonstrate dispersion because lower body neg-
ative pressure also increases circulating epinephrine (11,12). 
We did not measure dispersion of refractory periods; 
however, we did not observe any QT interval or T wave 
changes consistent with altered sympathetic neural input to 
the heart. 
Clinical implications. Recent observations in patients 
have suggested that parasympathetic influences do modulate 
ventricular refractoriness (10) and interrupt ventricular 
tachycardia (24,25). The present study documents the mod-
ulating effect of physiologically activated sympathetic influ-
ences on duration of ventricular refractory period, but we 
did not investigate such influences on spontaneous or induc-
ible arrhythmias in our patients. However, in a preliminary 
series of patients with repetitive monomorphic ventricular 
tachycardia from our laboratory (26), lower body Regative 
pressure appeared to be similar to infusion of isoproterenol 
in facilitation of tachycardia. Specifically, both interventions 
shortened right ventricular refractoriness and tachycardia 
cycle length and facilitated induction of ventricular tachy-
cardia during extrastimulus testing. At this time, we do not 
know whether lower body negative pressure will facilitate 
induction of clinically occurring ventricular tachycardias 
associated with prior myocardial infarction. Because nearly 
all such ventricular tachycardias are induced with pre-
mature stimulation alone and because at least short-term 
administration of a beta-blocking agent is not effective in 
preventing tachycardia induction, the frequency of facilita-
tion of such induction may not be common. However, re-
entry is the likely mechanism of these inducible ventricular 
tachycardias, and shortening of refractoriness in tissue crit-
ical to the circuit may facilitate tachycardia induction on 
occasion (7). 
Further work is needed to assess whether physiologic 
augmentation of sympathetic influences by lower body neg-
ative pressure during extrastimulus testing will be useful in 
predicting efficacy of adrenergic blockade, as has been 
demonstrated with isoproterenol (7). Because of the physi-
ologic activation of sympathetic influences, lower body 
negative pressure may be a better means than infused 
isoproterenol of testing responses of arrhythmias to beta-
adrenergic blocking drugs. 
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